The UCLA Jonsson Comprehensive Cancer Center has designed a Specialized Program of Research Excellence (SPORE) in lung cancer. This multi-disciplinary, translational research program addresses critical questions in a broad based research effort to enhance our understanding of lung cancer biology and develop more effective methods for the prevention diagnosis, and treatment of lung cancer. The UCLA Lung Cancer SPORE is led by experienced lung cancer researchers who have organized investigative teams to develop highly interactive research programs with a strong translational focus. These scientific programs will focus on: 1) Tumor Susceptibility, Genetic Mutations, and Risk of Lung Cancer; 2) A Combined CT-PET Approach to Optimize in vivo Lung Nodule Characterization; 3) Neuropeptide Signaling Antagonists for SCLC Therapy; 4) Genetic Immunotherapy for Lung Cancer; and 5) Chemokine Regulation of Angiogenesis in Lung Cancer. The translational focus of this research will be maintained in each scientific section by teams of both basic and applied investigators. A Developmental Research Program will award 3-5 new grants each years for highly innovative translational research. The selection and progress of these developmental programs will be monitored by the Developmental Programs and Executive Committees, as well as the Internal and External Advisory Boards. A Lung Cancer SPORE Career Development Program designed for both fellows and faculty will be implemented for the career development of translational lung cancer investigators. To promote the strong translational research emphasis we have instituted a Clinical Trials Core that will be responsible for initiating clinical trials that are based on the pre-clinical investigations in each of the laboratories. Additional cores for pathology, informatics and administration will serve to support all of the research programs within the SPORE. In addition to research based at UCLA, our Lung Cancer SPORE Program is designed to foster collaborative interactions regionally and nationally. Accordingly, we have selected an external advisory board comprised of cancer center directions within our region as well as nationally recognized translational lung cancer researchers. In collaboration with the Lung Cancer SPORE leadership, the Internal and External Advisory Boards will continually assess the progress of all aspects of the program. The UCLA Lung Cancer SPORE is designed for maximum flexibility so that resources can be focused on the most promising investigations with the greatest translational potential. The UCLA Lung Cancer SPORE constitutes a highly collaborative, multi-disciplinary translational research program designed to make a significant impact on lung cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-GRB-V (J1))
Program Officer
Ujhazy, Peter
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Internal Medicine/Medicine
Schools of Medicine
Los Angeles
United States
Zip Code
Lee, Jay M; Lee, Mi-Heon; Garon, Edward et al. (2017) Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration. Clin Cancer Res 23:4556-4568
Kawakita, Daisuke; Lee, Yuan-Chin Amy; Turati, Federica et al. (2017) Dietary fiber intake and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium. Int J Cancer 141:1811-1821
Boffetta, Paolo; Hayes, Richard B; Sartori, Samantha et al. (2016) Mouthwash use and cancer of the head and neck: a pooled analysis from the International Head and Neck Cancer Epidemiology Consortium. Eur J Cancer Prev 25:344-8
Miles, Fayth L; Chang, Shen-Chih; Morgenstern, Hal et al. (2016) Association of sugary beverages with survival among patients with cancers of the upper aerodigestive tract. Cancer Causes Control 27:1293-1300
Wyss, Annah B; Hashibe, Mia; Lee, Yuan-Chin Amy et al. (2016) Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium. Am J Epidemiol 184:703-716
Leoncini, Emanuele; Edefonti, Valeria; Hashibe, Mia et al. (2016) Carotenoid intake and head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Eur J Epidemiol 31:369-83
Hashim, D; Sartori, S; Brennan, P et al. (2016) The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium. Ann Oncol 27:1619-25
Myneni, Ajay A; Chang, Shen-Chih; Niu, Rungui et al. (2016) Raw Garlic Consumption and Lung Cancer in a Chinese Population. Cancer Epidemiol Biomarkers Prev 25:624-33
Conway, David I; Brenner, Darren R; McMahon, Alex D et al. (2015) Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer 136:1125-39
Chang, Shen-Chih; Goldstein, Binh Y; Mu, Lina et al. (2015) Plasma folate, vitamin B12, and homocysteine and cancers of the esophagus, stomach, and liver in a Chinese population. Nutr Cancer 67:212-23

Showing the most recent 10 out of 201 publications